Financial Freedom LLC’s VanEck Pharmaceutical ETF PPH Stock Holding History

Financial Freedom LLC’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$954K	Buy	8,723 +22	+0.3%	+$2.28K	0.44%	50
2026 Q1	$904K	Sell	8,701 -287	-3%	-$30.6K	0.45%	49
2025 Q4	$927K	Buy	8,988 +19	+0.2%	+$1.85K	0.46%	48
2025 Q3	$810K	Sell	8,969 -37	-0.4%	-$3.24K	0.4%	51
2025 Q2	$792K	Buy	9,006 +15	+0.2%	+$1.3K	0.43%	47
2025 Q1	$819K	Sell	8,991 -1,500	-14%	-$135K	0.47%	40
2024 Q4	$905K	Buy	10,491 +38	+0.4%	+$3.44K	0.48%	40
2024 Q3	$993K	Buy	10,453 +16	+0.2%	+$1.52K	0.53%	38
2024 Q2	$955K	Buy	10,437 +5,657	+118%	+$505K	0.54%	38
2024 Q1	$434K	Buy	+4,780	New	+$419K	0.26%	67

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Financial Freedom LLC's PPH Position: Q2 2026 in Review

Financial Freedom LLC increased its VanEck Pharmaceutical ETF (PPH) stake by 0.25% in Q2 2026, buying an estimated $2.28K and bringing the position to 8,723 shares worth $954K. The position accounts for 0.44% of the portfolio, ranked #50.

Financial Freedom LLC first reported a position in PPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $993K in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Financial Freedom LLC held 8,723 shares of VanEck Pharmaceutical ETF worth $954K as of Q2 2026.
Financial Freedom LLC bought 22 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.28K.
VanEck Pharmaceutical ETF made up 0.44% of Financial Freedom LLC's portfolio in Q2 2026, its #50 holding.
Financial Freedom LLC first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and has held it in 10 quarters since.
Financial Freedom LLC's VanEck Pharmaceutical ETF position peaked at $993K in Q3 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.